Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

PDL issues further licenses under its antibody humanization patents

Jan. 20, 1999

Idun obtains rights to technology with application to HIV and other diseases

Jan. 20, 1999

New neurological and immunological therapies basis of Neurocrine Biosciences-Caliper collaboration

Jan. 19, 1999

LeukoSite, Warner-Lambert collaborate on integrin antagonist research

Jan. 19, 1999

Targeted Genetics, Sangamo combine two novel technologies for drug discovery

Jan. 19, 1999

Palatin and Nihon Medi-Physics intend to develop radiopharmaceutical products

Jan. 18, 1999

Tenth HuMAb-Mouse licensing agreement for Medarex: Immunex granted broad rights

Jan. 18, 1999

Milestone reached by Cadus in drug discovery collaboration with SmithKline Beecham

Jan. 18, 1999

Rigel and Janssen enter drug discovery collaboration

Jan. 15, 1999

Isis and Abbott establish antisense target validation partnership

Jan. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...